Endogenous cell repair of chronic demyelination

Journal of Neuropathology and Experimental Neurology

Volumn 65, Issue 3, 2006, Pages 245-256

  Armstrong, Regina C ^a   Le, Tuan Q ^a   Flint, Nicole C ^a   Vana, Adam C ^a   Zhou, Yong Xing ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Cuprizone; Demyelinating disease; Differentiation; Fibroblast growth factor; Myelin repair; Oligodendrocyte progenitor

Indexed keywords

CUPRIZONE; FIBROBLAST GROWTH FACTOR 2;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CELL REGENERATION; CHRONIC DEMYELINATION; CHRONIC DISEASE; CONTROLLED STUDY; CORPUS CALLOSUM; DEMYELINATING DISEASE; DEMYELINATION; DISABILITY; FGF2 GENE; GENE; GENOTYPE; KNOCKOUT MOUSE; MOUSE; MULTIPLE SCLEROSIS; NERVE CELL DIFFERENTIATION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REMYELINIZATION; STEM CELL;

EID: 33646779566     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jnen.0000205142.08716.7e     Document Type: Article

References (51)

1. Prineas JW, Barnard RO, Kwon EE, et al. Multiple sclerosis: Remyelination of nascent lesions. Ann Neurol 1993;33:137-51
2. Raine CS, Wu E. Multiple sclerosis: Remyelination in acute lesions. J Neuropathol Exp Neurol 1993;52:199-204
3. Bruck W, Kuhlmarm T, Stadelmann C. Remyelination in multiple sclerosis. J Neurol Sci 2003;206:181-85
4. Chari DM, Blakemore WF. New insights into remyelination failure in multiple sclerosis: Implications for glial cell transplantation. Mult Scler 2002;8:271-77
5. Armstrong RC, Redwine JM, Messersmith DJ. Coronavirus induced demyelination and remyelination: Growth factor expression and function. In: Lavi E, Constantinescu CS, eds. Experimental Models of Multiple Sclerosis. New York, NY: Springer 2005:793-803
6. Reynolds R, Cenci di Bello I, Dawson M, et al. The response of adult oligodendrocyte progenitors to demyelination in EAE. Prog Brain Res 2001;132:165-74
7. Watanabe M, Toyama Y, Nishiyama A. Differentiation of proliferated NG2-positive glial progenitor cells in a remyelinating lesion. J Neurosci Res 2002;69:826-36
8. Solanky M, Maeda Y, Ming X, et al. Proliferating oligodendrocytes are present in both active and chronic inactive multiple sclerosis plaques. J Neurosci Res 2001;65:308-17
9. Chang A, Tourtellotte WW, Rudick R, et al. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 2002;346:165-73
10. Murtie JC, Zhou YX, Le TQ, et al. In vivo analysis of oligodendrocyte lineage development in postnatal FGF2 null mice. Glia 2005;49:542-54
11. Murtie JC, Zhou YX, Le TQ, et al. PDGF and FGF2 pathways regulate distinct oligodendrocyte lineage responses in experimental demyelination with spontaneous remyelination. Neurobiol Dis 2005;19:171-82
12. Armstrong RC, Le TQ, Frost EE, et al. Absence of fibroblast growth factor 2 promotes oligodendroglial repopulation of demyelinated white matter. J Neurosci 2002;22:8574-85
13. Matsushima GK, Morell P. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol 2001;11:107-16
14. Ludwin SK. Chronic demyelination inhibits remyelination in the central nervous system. An analysis of contributing factors. Lab Invest 1980;43:382-87
15. Tansey FA, Zhang H, Cammer W. Expression of carbonic anhydrase II mRNA and protein in oligodendrocytes during toxic demyelination in the young adult mouse. Neurochem Res 1996;21:411-16
16. Mason JL, Toews A, Hostettler JD, et al. Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions. Am J Pathol 2004;164:1673-82
17. Zhou M, Sutliff RL, Paul RJ, et al. Fibroblast growth factor 2 control of vascular tone. Nat Med 1998;4:201-7
18. Redwine JM, Armstrong RC. In vivo proliferation of oligodendrocyte progenitors expressing PDGFalphaR during early remyelination. J Neurobiol 1998;37:413-28
19. Messersmith DJ, Murtie JC, Le TQ, et al. Fibroblast growth factor 2 (FGF2) and FGF receptor expression in an experimental demyelinating disease with extensive remyelination. J Neurosci Res 2000;62:241-56
20. Hudson LD, Berndt JA, Puckett C, et al. Aberrant splicing of proteolipid protein mRNA in the dysmyelinating jimpy mutant mouse. Proc Natl Acad Sci U S A 1987;84:1454-58
21. Fruttiger M, Karlsson L, Hall AC, et al. Defective oligodendrocyte development and severe hypomyelination in PDGF-A knockout mice. Development 1999;126:457-67
22. Linnington C, Webb M, Woodhams PL. A novel myelin-associated glycoprotein defined by a mouse monoclonal antibody. J Neuroimmunol 1984;6:387-96
23. Gerdes J, Lemke H, Baisch H, et al. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984;133:1710-15
24. Mason JL, Langaman C, Morell P, et al. Episodic demyelination and subsequent remyelination within the murine central nervous system: Changes in axonal calibre. Neuropathol Appl Neurobiol 2001;27:50-58
25. Mallon BS, Shick HE, Kidd GJ, et al. Proteolipid promoter activity distinguishes two populations of NG2-positive cells throughout neonatal cortical development. J Neurosci 2002;22:876-85
26. Song SK, Yoshino J, Le TQ, et al. Demyelination increases radial diffusivity in mouse brain white matter. Neuroimage 2005;26:132-40
27. Steward O, Schauwecker PE, Guth L, et al. Genetic approaches to neurotrauma research: Opportunities and potential pitfalls of murine models. Exp Neurol 1999;157:19-42
28. Maeda Y, Solanky M, Menonna J, et al. Platelet-derived growth factor-alpha receptor-positive oligodendroglia are frequent in multiple sclerosis lesions. Ann Neurol 2001;49:776-85
29. Keirstead HS, Blakemore WF. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination. Adv Exp Med Biol 1999;468:183-97
30. Woodruff RH, Fruttiger M, Richardson WD, et al. Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS and their response following CNS demyelination. Mol Cell Neurosci 2004;25:252-62
31. McKinnon RD, Matsui T, Dubois-Dalcq M, et al. FGF modulates the PDGF-driven pathway of oligodendrocyte development. Neuron 1990;5:603-14
32. Wolswijk G, Noble M. Cooperation between PDGF and FGF converts slowly dividing O-2A adult progenitor cells to rapidly dividing cells with characteristics of O-2Aperinatal progenitor cells. J Cell Biol 1992;118:889-900
33. Frost EE, Nielsen JA, Le TQ, et al. PDGF and FGF2 regulate oligodendrocyte progenitor responses to demyelination. J Neurobiol 2003;54:457-72
34. Decker L, Picard-Riera N, Lachapelle F, et al. Growth factor treatment promotes mobilization of young but not aged adult subventricular zone precursors in response to demyelination. J Neurosci Res 2002;69:763-71
35. Ruffini F, Furlan R, Poliani PL, et al. Fibroblast growth factor-II gene therapy reverts the clinical course and the pathologic signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice. Gene Ther 2001;8:1207-13
36. Lachapelle F, Avellana-Adalid V, Nait-Oumesmar B, et al. Fibroblast growth factor-2 (FGF-2) and platelet-derived growth factor AB (PDGF AB) promote adult SVZ-derived oligodendrogenesis in vivo. Mol Cell Neurosci 2002;20:390-403
37. Butt AM, Dinsdale J. Fibroblast growth factor 2 induces loss of adult oligodendrocytes and myelin in vivo. Exp Neurol 2005;192:125-33
38. Teng YD, Mocchetti I, Taveira-DaSilva AM, et al. Basic fibroblast growth factor increases long-term survival of spinal motor neurons and improves respiratory function after experimental spinal cord injury. J Neurosci 1999;19:7037-47
39. Alzheimer C, Werner S. Fibroblast growth factors and neuroprotection. Adv Exp Med Biol 2002;513:335-51
40. Jungnickel J, Claus P, Gransalke K, et al. Targeted disruption of the FGF-2 gene affects the response to peripheral nerve injury. Mol Cell Neurosci 2004;25:444-52
41. Pluchino S, Quattrini A, Brambilla E, et al. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature 2003;422:688-94
42. Smith C, Berry M, Clarke WE, et al. Differential expression of fibroblast growth factor-2 and fibroblast growth factor receptor 1 in a scarring and nonscarring model of CNS injury in the rat. Eur J Neurosci 2001;13:443-56
43. Fortin D, Rom E, Sun H, et al. Distinct fibroblast growth factor (FGF)/FGF receptor signaling pairs initiate diverse cellular responses in the oligodendrocyte lineage. J Neurosci 2005;25:7470-79
44. Bansal R, Kumar M, Murray K, et al. Developmental and FGF-2-mediated regulation of syndecans (1-4) and glypican in oligodendrocytes. Mol Cell Neurosci 1996;7:276-88
45. Wang S, Sdrulla AD, diSibio G, et al. Notch receptor activation inhibits oligodendrocyte differentiation. Neuron 1998;21:63-75
46. John GR, Shankar SL, Shafit-Zagardo B, et al. Multiple sclerosis: Re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nat Med 2002;8:1115-21
47. Viehover A, Miller RH, Park SK, et al. Neuregulin: An oligodendrocyte growth factor absent in active multiple sclerosis lesions. Dev Neurosci 2001;23:377-86
48. Sussman CR, Vartanian T, Miller RH. The ErbB4 neuregulin receptor mediates suppression of oligodendrocyte maturation. J Neurosci 2005;25:5757-62
49. Lucchinetti C, Bruck W, Parisi J, et al. A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain 1999;122:2279-95
50. Holley JE, Gveric D, Newcombe J. Astrocyte characterization in the multiple sclerosis glial scar. Neuropathol Appl Neurobiol 2003;29:434-44
51. Armstrong RC, Dorn HH, Kufta CV. Pre-oligodendrocytes from adult human CNS. J Neurosci 1992;12:1538-47